Peter Marks
Senior Vice President of Molecule Discovery & Head of Infectious Disease, Eli Lilly and Company
Peter Marks is listed as Senior Vice President of Molecule Discovery & Head of Infectious Disease, Eli Lilly and Company. Peter is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Peter. Is this you? Claim this profile.
About
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development. In 2012, he joined the Food and Drug Administration and served as Director of the Center for Biologics Evaluation and Research from 2016 to 2025. He is currently Senior Vice President for Molecule Development and Head of Infectious Disease at Eli Lilly and Company, has published extensively, and is a member of the National Academy of Medicine.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Keynote Discussion Integrating product delivery and market access for the next generation of cell & gene therapies Speaker · 19 January 2027
- Plenary: How must healthcare and industry models evolve to achieve the elusive goal of improved patient access? Speaker · 19 January 2027
Spoke alongside
People who have shared a session with Peter at events on B2DB.
- Scott Gottlieb Partner · New Enterprise Associates 2 shared sessions
- George Eastwood Executive Director · Emily Whitehead Foundation 1 shared session
- Phung Osborn Vice President and Head of Global Market Access, Cell Therapy · Bristol Myers Squibb 1 shared session
- Susan Nichols Chief Executive Officer · Propel Biosciences 1 shared session